H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine

Author(s): Marina Borro, Maurizio Simmaco, Antonio Aceti, Sandro Barni, Assunta De Luca, Vittorio Fineschi, Paola Frati, Paolo Girardi, Monica Miozzo, Giulio Nati, Ferdinando Nicoletti, Daniele Santini, Paolo Marchetti

Journal Name: Current Pharmaceutical Biotechnology

Volume 17 , Issue 10 , 2016


Become EABM
Become Reviewer
Call for Editor

Abstract:

Many unsolved practical issues, from technical and scientific to ethical, legal and economic topics, are slowing down the translation of Personalized Medicine principles into medical practice. The Italian Society of Personalized Medicine exposes here its point of view, based on the real-world practice of precision medicine carried-out in Italian healthcare structures.

Keywords: H2020, Personalized Medicine, precision medicine.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 10
Year: 2016
Published on: 20 June, 2016
Page: [926 - 929]
Pages: 4
DOI: 10.2174/1389201017666160519112850
Price: $65

Article Metrics

PDF: 19
HTML: 3
EPUB: 2
PRC: 1